Vaccines

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Can genetically engineered bacteria help alleviate cold chain issues for oral vaccines?

Human challenge studies could allow us to better predict vaccines' real-world efficacy.

Could public health suffer if the pharma industry doesn’t learn to win back trust?

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

Is a vaccine for the common cold impossible? Scientists believe not

Can bioinformatics point the way towards a universal flu vaccine?

A universal flu vaccine is not impossible for the industry – we just need bioinformatics.

Bioterrorism concerns prompt the UK government to fund development of a vaccine for plague.

Why has Médecins Sans Frontières rejected an offer of free vaccines from Pfizer?